Skip to main content
. 2015 May 11;18(11):pyv052. doi: 10.1093/ijnp/pyv052

Table 1.

Demographic and Clinical Characteristics, Genotype Frequencies, and Lead and Cotinine Levels of the Good and Poor Responders to MPH in ADHD Participants

Good Responder (n=48) Poor Responder (n=30) P Value
Age, mean (SD) years 9.4 (2.3) 9.8 (2.8) 0.48
Female, n (%) 11 (22.9%) 5 (16.7%) 0.51
IQ, mean (SD) 108 (12) 105 (15) 0.41
Handedness (right), n (%) 42 (87.5%) 28 (93.3%) 0.34
CPT, mean (SD)
 Omission errors 64.5 (20.3) 68.3 (21.8) 0.45
 Commission errors 63.1 (17.0) 66.4 (17.9) 0.43
 Response time variability 64.3 (17.6) 63.7 (17.3) 0.88
SCWT
 Word test 45.1 (10.3) 45.4 (12.3) 0.92
 Color test 44.7 (11.0) 46.0 (10.5) 0.60
 Color-Word test 44.6 (9.5) 49.5 (14.9) 0.12
 Interference 52.0 (11.0) 55.8 (11.9) 0.15
ADHD-RS, mean (SD)
 Inattention 15.5 (6.2) 14.3 (5.1) 0.40
 Hyperactivity-impulsivity 10.7 (5.7) 11.1 (5.9) 0.77
 Total 26.2 (10.6) 25.5 (10.5) 0.76
ADHD subtypes, n (%) 0.64
 Combined 25 (52.1%) 15 (50.0%)
 Inattentive 19 (39.6%) 12 (40.0%)
 Hyperactive-impulsive 0 (0.0%) 1 (3.3%)
 Not otherwise specified 4 (8.3%) 2 (6.7%)
Comorbid disorders, n (%)
 Oppositional defiant disorder 4 (8.3%) 9 (30.0%) 0.01
 Anxiety disorder 0 (0.0%) 1 (3.3%) 0.20
Genotype
 DAT1, n (%) 0.63
  With 10/10 39 (81.3%) 23 (76.7%)
  Without 10/10 9 (18.7%) 7 (23.3%)
 DRD4, n (%) 0.64
  With 4/4 25 (52.1%) 14 (46.7%)
  Without 4/4 23 (47.9%) 16 (53.3%)
 ADRA2A MspI, n (%) 0.14
  G/G 19 (39.6%) 17 (56.7%)
  G/C+C/C 29 (60.4%) 13 (43.3%)
 ADRA2A DraI, n (%) 0.87
  C/C 12 (25.0%) 7 (23.3%)
  C/T+T/T 36 (75.0%) 23 (76.7%)
 SLC6A2 G1287A, n (%) 0.54
  G/G 21 (43.8%) 11 (36.7%)
  G/A+A/A 27 (56.2%) 19 (63.3%)
 SLC6A2 A-3081T, n (%) 0.68
  A/A 17 (35.4%) 12 (40.0%)
  A/T+T/T 31 (64.6%) 18 (60.0%)
Environmental measure
 Lead (µg/dL), mean (SD) 1.5 (0.4) 1.4 (0.4) 0.60
 Cotinine (µg/g), mean (SD) 0.6 (0.9) 0.8 (1.8) 0.41

ADHD, attention deficit hyperactivity disorder; ADHD-RS, ADHD rating scale; ADRA2A, alpha-2A adrenergic receptor gene; CPT, continuous performance test; DAT1, dopamine transporter gene; DRD4, dopamine D4 receptor gene; MPH, methylphenidate; SCWT, Stroop color word test; SLC6A2, norepinephrine transporter gene.